Delfi Diagnostics Stock
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Sign up today and learn more about Delfi Diagnostics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Delfi Diagnostics Stock
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
Founder and CEO
Chief Commercial Officer
Chief Scientific Officer
Senior Director, Genomic Science
Chief Financial Officer
Board of Directors